OLED microdisplay maker eMagin reported its financial results for Q1 2021. Revenues were $6.8 million up from $6.7 in Q1 2020. Operating loss was $2 million, up from $1.3 million in Q1 2020. Net loss was $7.4 million (including a $7.2 million warrant value loss).

eMagin SXGA OLED-XL microdisplay photo

At the end of March 31 2021, the company had $10.7 million in cash and equivalents. eMagin reports it is continuing to place down payments for equipment as part of the $39.1 million US government funds that were awarded last year to enhance its manufacturing capabilities in the US.

The microdisplay market is heating up, in both the established defense, medical and industrial sectors and in the consumer markets (AR and VR) which are only now emerging. To learn more about the OLED microdisplay market (including our views on the disruptive microLED technologies), check out our OLED Microdisplay Market Report.

Tags:
Cambridge Isotope Laboratories - Deutreated Reagents and High-Purity Gases for OLEDsCambridge Isotope Laboratories - Deutreated Reagents and High-Purity Gases for OLEDs